Neurovascular Devices – Market Insights – Europe

The European neurovascular device market will see strong growth through 2032 driven by the launch and increasing adoption of new devices backed by favorable clinical data as well as access to the neurovascular devices, and rising demand for neurovascular procedures among the expanding patient population due to the urgent and severe nature of the neurovascular disease treatment procedures.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for neurovascular devices in Europe from 2019 through 2032.

The flow-diverting device market is seeing moderate growth.

How will adoption of flow-diverting devices impact the neurovascular embolization coil and coiling-assist device markets?

Which strategies are competitors adopting to gain a competitive-edge over other competitors in the flow-diverting device market?

How has the competitive landscape changed with the emergence of new competitors and products?

Many competitors are entering the neurovascular thrombectomy device market in Europe.

How will new products impact the neurovascular thrombectomy device market?

What challenges will new companies encounter in this space? Will they capture significant share from existing competitors?

Neurovascular thrombectomy devices and neurovascular embolization devices fueled the growth of overall neurovascular device market.

How much growth is expected in these market segments in the European countries?

How will the uptake of these devices vary across the countries covered?

Clinical data results will play an important role in driving the adoption of neurovascular devices.

Which clinical trials were recently conducted in this market?

What is the expected impact of these clinical trials on the market dynamics?

Table of contents

Neurovascular Devices - Market Insights - Europe

Yukta Munjal

Yukta Munjal is an associate analyst on the Cardiovascular Medtech Insights team at Clarivate, specializing in the peripheral vascular device market. Yukta holds a Bachelor’s degree in Pharmaceutical Sciences from Ram-Eesh Institute of Vocational and Technical Education, Greater Noida and M.Pharm in Pharmaceutical Analysis from Delhi Pharmaceutical Sciences and Research University, New Delhi.

Contact sales Login to access report

Back to all Medtech Insights reports